1352 related articles for article (PubMed ID: 15807870)
1. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
2. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
[TBL] [Abstract][Full Text] [Related]
3. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin levels in acromegaly--a significant role for adipose tissue and fasting insulin/glucose ratio.
Bolanowski M; Milewicz A; Bidzińska B; Jedrzejuk D; Daroszewski J; Mikulski E
Med Sci Monit; 2002 Oct; 8(10):CR685-9. PubMed ID: 12388920
[TBL] [Abstract][Full Text] [Related]
5. Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance.
Quilliot D; Alla F; Böhme P; Bruntz JF; Hammadi M; Dousset B; Ziegler O; Zannad F
Int J Obes (Lond); 2005 Nov; 29(11):1321-8. PubMed ID: 16116494
[TBL] [Abstract][Full Text] [Related]
6. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.
Minuto F; Resmini E; Boschetti M; Arvigo M; Sormani MP; Giusti M; Ferone D; Barreca A
Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656
[TBL] [Abstract][Full Text] [Related]
7. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH.
Kawamata T; Inui A; Hosoda H; Kangawa K; Hori T
Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003
[TBL] [Abstract][Full Text] [Related]
8. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.
Bogazzi F; Di Bello V; Palagi C; Donne MG; Di Cori A; Gavioli S; Talini E; Cosci C; Sardella C; Brogioni S; Mariani M; Martino E
Clin Endocrinol (Oxf); 2005 May; 62(5):590-6. PubMed ID: 15853830
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
[TBL] [Abstract][Full Text] [Related]
10. Gamma knife radiosurgery for acromegaly--long-term experience.
Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
[TBL] [Abstract][Full Text] [Related]
11. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment.
Zimmermann-Belsing T; Juul A; Juul Holst J; Feldt-Rasmussen U
Growth Horm IGF Res; 2004 Jun; 14(3):235-44. PubMed ID: 15125885
[TBL] [Abstract][Full Text] [Related]
12. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
14. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients.
Sesti G; Sciacqua A; Scozzafava A; Vatrano M; Angotti E; Ruberto C; Santillo E; Parlato G; Perticone F
J Hypertens; 2007 Feb; 25(2):471-7. PubMed ID: 17211256
[TBL] [Abstract][Full Text] [Related]
16. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
17. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis.
Toussirot E; Nguyen NU; Dumoulin G; Aubin F; Cédoz JP; Wendling D
Rheumatology (Oxford); 2005 Jan; 44(1):120-5. PubMed ID: 15466894
[TBL] [Abstract][Full Text] [Related]
18. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
19. Insulin sensitivity is impaired in adults with varying degrees of GH deficiency.
Murray RD; Shalet SM
Clin Endocrinol (Oxf); 2005 Feb; 62(2):182-8. PubMed ID: 15670194
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine levels in acromegaly patients.
Hekimsoy Z; Ozmen B; Ulusoy S
Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
